Autism spectrum disorder and GABA levels in children with succinic semialdehyde dehydrogenase deficiency
Developmental Medicine & Child Neurology · 2023
DOI: 10.1111/dmcn.15659 ↗Kurz gefasst
Fachartikel in der Zeitschrift Developmental Medicine & Child Neurology, 2023. Verfasst von Itay Tokatly Latzer und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA. Hauptthemen laut MEDLINE: Autism Spectrum Disorder. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: NICHD NIH HHS, National Institute of Child Health and Human Development.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Aim
To elucidate the etiological aspects of autism spectrum disorder (ASD) in succinic semialdehyde dehydrogenase deficiency (SSADHD), related to dysregulation of γ‐aminobutyric acid (GABA) and the imbalance of excitatory and inhibitory neurotransmission.
Method
In this prospective, international study, individuals with SSADHD underwent neuropsychological assessments, as well as biochemical, neurophysiological, and neuroimaging evaluations.
Results
Of the 29 individuals (17 females) enrolled (median age [IQR] 10 years 5 months [5 years 11 months–18 years 1 month]), 16 were diagnosed with ASD. ASD severity significantly increased with age ( r = 0.67, p < 0.001) but was inversely correlated with plasma GABA ( r = −0.67, p < 0.001) and γ‐hydroxybutyrate levels ( r = −0.538, p = 0.004), and resting motor threshold as measured by transcranial magnetic stimulation ( r = −0.44, p = 0.03). A discriminative analysis indicated that an age older than 7 years 2 months ( p = 0.004) and plasma GABA levels less than 2.47 μM ( p = 0.01) are the threshold values beyond which the likelihood of ASD presenting in individuals with SSADHD is increased.
Interpretation
ASD is prevalent but not universal in SSADHD, and it can be predicted by lower levels of plasma GABA and GABA‐related metabolites. ASD severity in SSADHD increases with age and the loss of cortical inhibition. These findings add insight into the pathophysiology of ASD and may facilitate its early diagnosis and intervention in individuals with SSADHD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
- Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel.
- Human Neurobehavioral Core Services, Division of Neurology, Boston Children's Hospital, Boston, MA, USA.
- Rosamund Stone Zander Translational Neuroscience Center, Boston Children's Hospital, MA, USA.
- Department of Neuroscience, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.
- Neurometabolic Unit, Neurology Department, Institut de Recerca, Hospital Sant Joan de Déu, Barcelona, Spain.
ORCID-Profile: Itay Tokatly Latzer, Àngeles García-Cazorla, Alexander Rotenberg, Jean-Baptiste Roullet, Phillip L Pearl
Förderung
- NICHD NIH HHS
- National Institute of Child Health and Human Development
Zitieren
APA
Tokatly Latzer, I., Hanson, E., Bertoldi, M., García-Cazorla, À., Tsuboyama, M., MacMullin, P., Rotenberg, A., Roullet, J. B., Pearl, P. L., & SSADH Deficiency Investigators Consortium (2023). Autism spectrum disorder and GABA levels in children with succinic semialdehyde dehydrogenase deficiency. Developmental Medicine & Child Neurology. https://doi.org/10.1111/dmcn.15659
Vancouver
Tokatly Latzer I, Hanson E, Bertoldi M, García-Cazorla À, Tsuboyama M, MacMullin P, et al. Autism spectrum disorder and GABA levels in children with succinic semialdehyde dehydrogenase deficiency. Developmental Medicine & Child Neurology. 2023. doi:10.1111/dmcn.15659
BibTeX
@article{TokatlyLatzer2023,
author = {Tokatly Latzer, Itay and Hanson, Ellen and Bertoldi, Mariarita and García-Cazorla, Àngeles and Tsuboyama, Melissa and MacMullin, Paul and Rotenberg, Alexander and Roullet, Jean-Baptiste and Pearl, Phillip L and SSADH Deficiency Investigators Consortium, SSADH Deficiency Investigators Consortium},
title = {Autism spectrum disorder and GABA levels in children with succinic semialdehyde dehydrogenase deficiency},
journal = {Developmental Medicine & Child Neurology},
year = {2023},
doi = {10.1111/dmcn.15659}
}
EUVIMED